Pain therapy with oxycodone/naloxone prolonged-release combination: case report

Feliks Błaszczyk; Aleksandra Droń

doi:10.5114/wo.2013.37911

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2013
vol. 17

Send email

Copy url:

abstract:

Case report

Pain therapy with oxycodone/naloxone prolonged-release combination: case report

Feliks Błaszczyk

,

Aleksandra Droń

Contemp Oncol (Pozn) 2013; 17 (4): 404-406

DOI: https://doi.org/10.5114/wo.2013.37911

Online publish date: 2013/10/07

View full text Get citation

PlumX metrics:

Pain afflicts patients suffering from many chronic diseases and is present in 80% of cases of patients with advanced cancer who suffer from persistent pain. The aim of the pain treatment is to achieve the maximum analgesic effect while minimizing side effects. The main analgesic agent – morphine is unfortunately a therapy associated with gastrointestinal side effects. It appears that the combination of oxycodone and naloxone available as Targin® (Mundipharma) is an alternative. The paper presents a case of a 45-year-old patient who was treated effectively with oxycodone/naloxone prolonged-release tablets. This treatment has proven to be effective in providing pain and constipation control.

keywords:

Pain therapy with oxycodone/naloxone prolonged-release combination: case report

Feliks Błaszczyk , Aleksandra Droń

pain, constipation, opioids, oxycodone/naloxone

Feliks Błaszczyk

,

Aleksandra Droń